- Home
- VOD vs BNTX Comparison
VOD vs BNTX Comparison
Compare VOD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOD
- BNTX
- Stock Information
- Founded
- VOD 1984
- BNTX 2008
- Country
- VOD United Kingdom
- BNTX Germany
- Employees
- VOD N/A
- BNTX N/A
- Industry
- VOD Telecommunications Equipment
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VOD Telecommunications
- BNTX Health Care
- Exchange
- VOD Nasdaq
- BNTX Nasdaq
- Market Cap
- VOD 23.1B
- BNTX 25.0B
- IPO Year
- VOD 1988
- BNTX 2019
- Fundamental
- Price
- VOD $10.20
- BNTX $106.53
- Analyst Decision
- VOD Sell
- BNTX Strong Buy
- Analyst Count
- VOD 1
- BNTX 18
- Target Price
- VOD N/A
- BNTX $141.55
- AVG Volume (30 Days)
- VOD 16.9M
- BNTX 1.2M
- Earning Date
- VOD 07-01-2025
- BNTX 08-04-2025
- Dividend Yield
- VOD 4.86%
- BNTX N/A
- EPS Growth
- VOD N/A
- BNTX N/A
- EPS
- VOD N/A
- BNTX N/A
- Revenue
- VOD $40,475,572,836.00
- BNTX $2,968,331,171.00
- Revenue This Year
- VOD $7.49
- BNTX N/A
- Revenue Next Year
- VOD $0.08
- BNTX $10.68
- P/E Ratio
- VOD N/A
- BNTX N/A
- Revenue Growth
- VOD 14.43
- BNTX 0.61
- 52 Week Low
- VOD $8.00
- BNTX $76.53
- 52 Week High
- VOD $10.60
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- VOD 57.15
- BNTX 54.09
- Support Level
- VOD $10.03
- BNTX $102.24
- Resistance Level
- VOD $10.35
- BNTX $108.56
- Average True Range (ATR)
- VOD 0.13
- BNTX 4.00
- MACD
- VOD -0.03
- BNTX -0.35
- Stochastic Oscillator
- VOD 61.54
- BNTX 20.76
About VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses in more than 20 countries. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns a cable network after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK it acts as a mobile operator and is attempting a merger with CK Hutchison. In 2024 Vodafone divested its Spanish and Italian divisions, given their low returns on invested capital.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.